{"mainPropery":{"diseaseId":6523,"diseaseName":"Glutaric acidemia type II","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/6523/glutaric-acidemia-type-ii","synonyms":["Glutaric acidemia type 2","Glutaric acidemia 2","Glutaric aciduria 2","GA 2","Ethylmalonic-adipicaciduria","Multiple Acyl-CoA dehydrogenase deficiency","EMA","MADD"],"synonyms-with-source":[{"name":"Glutaric acidemia type 2"},{"name":"Glutaric acidemia 2"},{"name":"Glutaric aciduria 2"},{"name":"GA 2"},{"name":"Ethylmalonic-adipicaciduria"},{"name":"Multiple Acyl-CoA dehydrogenase deficiency"},{"name":"EMA"},{"name":"MADD"}],"identifiers":[{"identifierType":"OMIM","identifierId":"231680"},{"identifierType":"ORPHANET","identifierId":"26791"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases"},{"diseaseTypeId":4,"diseaseTypeName":"Heart Diseases"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases"},{"diseaseTypeId":37,"diseaseTypeName":"Newborn Screening"}],"organizations":[{"resourceID":175,"resourceName":"FOD (Fatty Oxidation Disorder) Family Support Group","abbreviation":"","address1":"P.O. Box 54","address2":"","address3":"","address4":"","address5":"","city":"Okemos","state":"MI","zip":"48805-0054","country":"United States","phone":"+1-517-381-1940 [8am - 8pm EST every day]","tty":"","tollFree":"","fax":"+1-866-290-5206","email":"deb@fodsupport.org","url":"https://fodsupport.org/","freeText":""},{"resourceID":176,"resourceName":"United Mitochondrial Disease Foundation","abbreviation":"","address1":"8085 Saltsburg Road, Suite 201","address2":"","address3":"","address4":"","address5":"","city":"Pittsburgh","state":"PA","zip":"15239 ","country":"United States","phone":"+1-412-793-8077 ","tty":"","tollFree":"1-888-317-8633","fax":"+1-412-793-6477 ","email":"info@umdf.org","url":"https://www.umdf.org","freeText":""},{"resourceID":221,"resourceName":"Organic Acidemia Association","abbreviation":"","address1":"9040 Duluth Street","address2":"","address3":"","address4":"","address5":"","city":"Golden Valley","state":"MN","zip":"55427","country":"United States","phone":"763-559-1797","tty":"","tollFree":"","fax":"866-539-4060","email":"mkstagni@gmail.com","url":"http://www.oaanews.org/","freeText":""},{"resourceID":138,"resourceName":"Metabolic Support UK","abbreviation":"","address1":"5 Hilliards Court","address2":"Sandpiper Way","address3":"Chester Business Park","address4":"","address5":"","city":"Chester","state":"","zip":"CH4 9QP","country":"United Kingdom","phone":"0845 241 2173","tty":"","tollFree":"0800 652 3181 ","fax":"","email":"https://www.metabolicsupportuk.org/contact-us","url":"https://www.metabolicsupportuk.org","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/231680' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='https://www.ncbi.nlm.nih.gov/pubmed/?term=Glutaric+acidemia+type+II+%5Bti%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Glutaric acidemia type II. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://www.ghr.nlm.nih.gov/condition=glutaricacidemiatypeii' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Glutaric acidemia type II. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":350,"resourceId":1167,"resourceName":"Baby's First Test","descriptionText":"<a href='https://www.babysfirsttest.org/newborn-screening/conditions/glutaric-acidemia-type-ii' target='_blank'>Baby's First Test</a> is the nation's newborn screening education center for families and providers. This site provides information and resources about screening at the local, state, and national levels and serves as the Clearinghouse for newborn screening information.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":824,"resourceId":1535,"resourceName":"Glutaric aciduria 2","descriptionText":"The <a href='http://newbornscreeningcodes.nlm.nih.gov/nb/sc/condition/GA-2 ' target='_blank'>Newborn Screening Coding and Terminology Guide</a> has information on the standard codes used for  newborn screening tests. Using these standards helps compare data across different laboratories. This resource was created by the National Library of Medicine.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1264,"resourceId":176,"resourceName":"United Mitochondrial Disease Foundation","descriptionText":"You can submit a question to <a href='http://pi.umdf.org/l/346741/2017-11-01/7vxq' target='_blank'>Ask the Mito Doc</a>, a service of the United Mitochondrial Diseases Foundation. Information contained in Ask the Mito Doc<small><sup>SM</sup></small> is for informational and educational purposes only.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1321,"resourceId":1982,"resourceName":"National Newborn Screening and Global Resource Center","descriptionText":"<a href='https://www.newbornscreening.info/iva-isovaleric-acidemia/' target='_blank'>National Newborn Screening and Global Resource Center</a> (NNSGRC) provides information and resources in the area of newborn screening and genetics to benefit health professionals, the public health community, consumers and government officials.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/378/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022470' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=26791' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1535,"resourceId":2166,"resourceName":"ACTion (ACT) sheet","descriptionText":"An  <a href='https://www.acmg.net/PDFLibrary/Glutaric-Aciduria-Type-2-ACT-Sheet.pdf' target='_blank'>ACTion (ACT) sheet </a> is available for this condition that describes the short-term actions a health professional should follow when an infant has a positive newborn screening result. ACT sheets were developed by experts in collaboration with the American College of Medical Genetics.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1546,"resourceId":2174,"resourceName":"Algorithm","descriptionText":"An <a href='https://www.acmg.net/PDFLibrary/C4-C5-Elevated-Algorithm.pdf' target='_blank'>Algorithm</a> flowchart is available for this condition for determining the final diagnosis in an infant with a positive newborn screening result. Algorithms are developed by experts in collaboration with the American College of Medical Genetics.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1547,"resourceId":2175,"resourceName":"Screening, Technology And Research in Genetics (STAR-G) Project","descriptionText":"The <a href='http://www.newbornscreening.info/Parents/fattyaciddisorders/GA2.html' target='_blank'>Screening, Technology And Research in Genetics (STAR-G) Project</a> has a fact sheet on this condition, which was written specifically for families that have received a diagnosis as a result of newborn screening. This fact sheet provides general information about the condition and answers questions that are of particular concern to parents.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1702,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='https://www.orpha.net/data/patho/Pro/en/Emergency_BIMDG_LongChainFatOxidation-enPro8768.pdf' target='_blank'>Orphanet Emergency Guidelines</a> is an article which is expert-authored and peer-reviewed that is intended to guide health care professionals in emergency situations involving this condition. &nbsp;","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:231680' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":3702,"questionText":"What is glutaric acidemia type II?","answerText":"<strong>Glutaric acidemia type II</strong> (GA2) is a disorder that interferes with the body's ability to break down <a href=\"http://ghr.nlm.nih.gov/handbook/howgeneswork/protein\" target=_blank>proteins</a> and fats to produce energy. The severity of GA2 varies widely among affected individuals. Some have a very severe form which appears in the neonatal period and may be fatal; individuals with this form may be born with physical abnormalities including brain malformations, an enlarged liver, kidney malformations, unusual facial features, and genital abnormalities. They may also emit an odor resembling sweaty feet. Others have a less severe form which may appear in infancy, childhood, or even adulthood. Most often, GA2 first appears in infancy or early childhood as a sudden episode of a <a href=\"http://www.newbornscreening.info/GlossaryTerms/metabolicCrisis.html\" target=_blank>metabolic crisis</a> that can cause weakness, behavior changes (such as poor feeding and decreased activity) and vomiting.[2595] GA2 is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=_blank>autosomal recessive</a> manner and is caused by mutations in the <a class=\"geneSymbol link-dapple\" title=\"E T F A\" href=\"http://www.ghr.nlm.nih.gov/gene/ETFA\" target=_blank><span><em>ETFA</em></span></a>, <a class=\"geneSymbol link-dapple\" title=\"E T F B\" href=\"http://www.ghr.nlm.nih.gov/gene/ETFB\" target=_blank><span><em>ETFB</em></span></a>, or <a class=\"geneSymbol link-dapple\" title=\"E T F D H\" href=\"http://www.ghr.nlm.nih.gov/gene/ETFDH\" target=_blank><span><em>ETFDH</em></span></a>&nbsp;<em></em>genes.[2595] Treatment varies depending on the severity and symptoms but often includes a low fat, low protein, and high carbohydrate diet.[6149]","dateModified":"2013-08-16T11:15:00"},"basicQuestions":[{"questionId":7000,"questionText":"What are the signs and symptoms of glutaric acidemia type II?","answerText":"Signs and symptoms of glutaric acidemia type II (GA2) can vary widely depending on the age of onset and severity of the condition in each affected individual. In most cases, the condition appears in infancy or early childhood as a sudden episode called a <a href=\"http://www.newbornscreening.info/GlossaryTerms/metabolicCrisis.html\" target=_blank>metabolic crisis</a> which causes weakness; behavior changes such as poor feeding and decreased activity; and vomiting. These crises can be life-threatening and may be triggered by common childhood illnesses or other stresses on the body.<br><br>The most severe cases may appear in the neonatal period (within the first 4 weeks of life) and may also be characterized by the presence of physical abnormalities at birth. These abnormalities may include brain malformations; an enlarged liver (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003275.htm\" target=_blank>hepatomegaly</a>); a weakened and enlarged heart (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000168.htm\" target=_blank>dilated cardiomyopathy</a>); fluid-filled cysts and other malformations of the kidneys; unusual facial features; and genital abnormalities. Some affected individuals have a characteristic odor resembling sweaty feet.<br><br>Other cases are less severe and may appear later in childhood, in adolescence, or in adulthood. In the most mild cases, muscle weakness may be the first sign of the disorder.[6150]","dateModified":"2013-08-16T12:32:00","resourceClassificationName":"Symptoms","references":[{"referenceId":6150,"authors":"","articleTitle":"Glutaric acidemia type II","bookWebsiteJournalTitle":"Genetics Home Reference","date":"July 2008","url":"http://www.ghr.nlm.nih.gov/condition/glutaric-acidemia-type-ii","dateAccessed":"2013-08-16T00:00:00"}]},{"questionId":5328,"questionText":"<p>How might glutaric acidemia type II be treated?</p>","answerText":"The goal of treatment is to prevent long-term problems. However, children who have repeated metabolic crises may develop life-long learning problems. Individuals with glutaric acidemia type II should consult with a metabolic doctor and a <span style=\"text-decoration: underline;\"><a href=\"http://www.newbornscreening.info/GlossaryTerms/dietician.html\" target=\"_blank\">dietician</a></span> who can help to develop an appropriate dietary plan. Some treatments may be recommended for some children but not for others. When necessary, treatment should be continued throughout the lifetime. The following treatments are often recommended:[2596][11762]\r\n<ul>\r\n    <li>Avoidance of fasting. Infants and young children with glutaric acidemia type II should eat frequent meals in order to prevent hypoglycemia and metabolic crises.</li>\r\n    <li>A low-fat, low-protein, high-carbohydrate diet may be advised.</li>\r\n    <li><a href=\"http://www.newbornscreening.info/GlossaryTerms/riboflavin.html\" target=\"_blank\">Riboflavin</a>, <a href=\"http://www.newbornscreening.info/GlossaryTerms/l_carnitine.html\" target=\"_blank\">L-carnitine</a> and <a href=\"http://www.newbornscreening.info/GlossaryTerms/glycine.html\" target=\"_blank\">glycine</a> supplements may be needed. These supplements help the body create energy.</li>\r\n    <li>Alert the child's doctor if they should become ill, as illness can trigger a metabolic crisis.</li>\r\n</ul>","dateModified":"2016-06-24T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":2596,"authors":"","articleTitle":"Glutaric acidemia, type 2","bookWebsiteJournalTitle":"STAR-G Genetic Fact Sheets For Parents","date":"August 16 2013","volume":"","pages":"","url":"http://www.newbornscreening.info/Parents/fattyaciddisorders/GA2.html","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11762,"authors":"Olpin S","articleTitle":"Multiple acyl-CoA dehydrogenation deficiency (MADD)","bookWebsiteJournalTitle":"Orphanet","date":"February 2014","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=26791","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":10933,"phenoTypeName":"Elevated serum creatine kinase","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3465,"phenoTypeName":"Exercise-induced muscle fatigue","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13041,"phenoTypeName":"Hypoglycemia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3980,"phenoTypeName":"Myalgia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5281,"phenoTypeName":"Proximal muscle weakness","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3991,"phenoTypeName":"3-Methylglutaric aciduria","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11314,"phenoTypeName":"Abnormality of the pinna","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8737,"phenoTypeName":"Areflexia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4779,"phenoTypeName":"Congestive heart failure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5702,"phenoTypeName":"Decreased liver function","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10926,"phenoTypeName":"Decreased plasma carnitine","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11344,"phenoTypeName":"Depressed nasal bridge","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6235,"phenoTypeName":"Difficulty climbing stairs","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13402,"phenoTypeName":"Dysphagia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13726,"phenoTypeName":"Dyspnea","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4319,"phenoTypeName":"Elevated hepatic transaminase","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9657,"phenoTypeName":"Elevated plasma acylcarnitine levels","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14520,"phenoTypeName":"Ethylmalonic aciduria","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6230,"phenoTypeName":"Exercise intolerance","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15339,"phenoTypeName":"Fatigable weakness of neck muscles","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13239,"phenoTypeName":"Feeding difficulties","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14589,"phenoTypeName":"Glutaric aciduria","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13782,"phenoTypeName":"Hepatic periportal necrosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10428,"phenoTypeName":"High forehead","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13089,"phenoTypeName":"Hyperammonemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10993,"phenoTypeName":"Hyperlordosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6290,"phenoTypeName":"Increased intramyocellular lipid droplets","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":2176,"phenoTypeName":"Increased lactate dehydrogenase level","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14576,"phenoTypeName":"Lactic acidosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5237,"phenoTypeName":"Lacticaciduria","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13040,"phenoTypeName":"Metabolic acidosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4292,"phenoTypeName":"Respiratory failure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14505,"phenoTypeName":"Skeletal muscle atrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5618,"phenoTypeName":"Telecanthus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13400,"phenoTypeName":"Vomiting","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9852,"phenoTypeName":"Wide anterior fontanel","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10012,"phenoTypeName":"Abnormality of the genital system","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":3876,"phenoTypeName":"Acute pancreatitis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":11774,"phenoTypeName":"Arrhythmia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":4782,"phenoTypeName":"Cardiomyopathy","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":5170,"phenoTypeName":"Cardiorespiratory arrest","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":9387,"phenoTypeName":"Encephalopathy","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13847,"phenoTypeName":"Gliosis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":11233,"phenoTypeName":"Gray matter heterotopia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":14222,"phenoTypeName":"Inability to walk","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":9851,"phenoTypeName":"Macrocephaly","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":10044,"phenoTypeName":"Polycystic kidney dysplasia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":5190,"phenoTypeName":"Poor head control","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13724,"phenoTypeName":"Restrictive ventilatory defect","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":10213,"phenoTypeName":"Reye syndrome-like episodes","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":14503,"phenoTypeName":"Rhabdomyolysis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":5270,"phenoTypeName":"Scapular winging","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13100,"phenoTypeName":"Abnormal facial shape","percentRanges":"-"},{"phenoTypeId":13038,"phenoTypeName":"Acidosis","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":5625,"phenoTypeName":"Developmental cataract","percentRanges":"-"},{"phenoTypeId":5236,"phenoTypeName":"Electron transfer flavoprotein-ubiquinone oxidoreductase defect","percentRanges":"-"},{"phenoTypeId":6219,"phenoTypeName":"Elevated circulating glutaric acid concentration","percentRanges":"-"},{"phenoTypeId":4315,"phenoTypeName":"Generalized aminoaciduria","percentRanges":"-"},{"phenoTypeId":14534,"phenoTypeName":"Glycosuria","percentRanges":"-"},{"phenoTypeId":5695,"phenoTypeName":"Hepatic steatosis","percentRanges":"-"},{"phenoTypeId":9407,"phenoTypeName":"Hypoglycemic coma","percentRanges":"-"},{"phenoTypeId":10276,"phenoTypeName":"Jaundice","percentRanges":"-"},{"phenoTypeId":9419,"phenoTypeName":"Muscle weakness","percentRanges":"-"},{"phenoTypeId":13408,"phenoTypeName":"Nausea","percentRanges":"-"},{"phenoTypeId":7378,"phenoTypeName":"Neonatal death","percentRanges":"-"},{"phenoTypeId":9389,"phenoTypeName":"Pachygyria","percentRanges":"-"},{"phenoTypeId":10045,"phenoTypeName":"Proximal tubulopathy","percentRanges":"-"},{"phenoTypeId":13722,"phenoTypeName":"Pulmonary hypoplasia","percentRanges":"-"},{"phenoTypeId":14171,"phenoTypeName":"Renal cortical cysts","percentRanges":"-"},{"phenoTypeId":13728,"phenoTypeName":"Respiratory distress","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Glutaric_acidemia_type_II"}